Verapamil (VP) improves the outcome after renal transplantation (CRT)
Calcium antagonists (CATs) have a role in the management of certain types of renal insufficiency [6, 15]. These include prophylaxis against post-transplant-associated acute renal failure and cyclosporine A (CsA)-induced renal dysfunction. For the transplanted kidney, CATs may be beneficial in several settings. First, a CAT during organ procurement protects the kidney during ischemic periods . Second, CATs given perioperatively protect the kidney during reperfusion and early after transplantation . Third, CATs also offer protection against CsA nephrotoxicity .
Key wordsRenal transplantation Verapamil
Unable to display preview. Download preview PDF.
- 2.Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, Peters P, Risser R, Sandor Z, Seney F (1991) Verapamil improves the outcome after cadaver renal transplantation. JASN (in press)Google Scholar
- 3.Dy G, Raja R, Mendez M (1991) The clinical and biochemical effect of calcium channel blockers (CCB) in organ transplantation recipients (TR) on cyclosporine (CsA). Transplant Proc (in press)Google Scholar
- 6.Loutzenhiser R, Epstein M (1990) The renal hemodynamic effects of calcium antagonists. In: Epstein M (ed) Calcium antagonists and the kidney. Hanley & Belfus, Philadelphia, pp 33–73Google Scholar
- 9.Neumayer HH, Wagner K (1987) Prevention of delayed graft function in cadaver kidney transplant by diltiazem: outcome of two prospective, randomized clinical trials. J Cardiovasc Pha-racol 10:170–177Google Scholar
- 10.Palmer B, Dawidson I, Sagalowsky A, Sandor Z, Lu C (1991) Calcium channel blockers improve the outcome of cadaveric renal transplantation. Transplantation (in press)Google Scholar
- 11.Prisch JD, Voss BJ, D’Alessandro AM, et al (1990) A controlled, double-blind, randomized trial of verapamil in cyclosporine -treated cadaver renal transplant patients. Abstract presented at the American Society of Transplant Physicians, 9th Annual Meeting, Chicago, May 29–30Google Scholar